End-of-day quote
Other stock markets
|
||
- EUR | - |
2023 | Valerio Therapeutics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Onxeo SA has Changed its Name to Valerio Therapeutics | CI |
Sales 2021 | 4.06M 4.34M 348M | Sales 2022 | 1.44M 1.54M 124M | Capitalization | 15.64M 16.72M 1.34B |
---|---|---|---|---|---|
Net income 2021 | -5M -5.35M -428M | Net income 2022 | -19M -20.32M -1.63B | EV / Sales 2021 | 7.53 x |
Net cash position 2021 | 7.95M 8.5M 681M | Net cash position 2022 | 4.45M 4.76M 381M | EV / Sales 2022 | 7.75 x |
P/E ratio 2021 |
-6
x | P/E ratio 2022 |
-0.76
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 73.93% |
Managers | Title | Age | Since |
---|---|---|---|
Shefali Agarwal
CEO | Chief Executive Officer | 50 | 31/05/21 |
Ashish Gulati
CTO | Chief Tech/Sci/R&D Officer | - | - |
Julien Miara
BRD | Director/Board Member | - | 16/09/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jacques Mallet
BRD | Director/Board Member | 64 | 13/10/21 |
Khalil Barrage
BRD | Director/Board Member | 59 | - |
Director/Board Member | 60 | 28/06/11 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- ALVIO Stock
- C4X Stock